Literature DB >> 8976638

Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Y Fujikawa1, A Sabokbar, S Neale, N A Athanasou.   

Abstract

OBJECTIVE: To determine whether synovial macrophages and monocytes isolated from patients with rheumatoid arthritis patients are capable of differentiating into osteoclastic bone resorbing cells; and the cellular and humoral conditions required for this to occur.
METHODS: Macrophages isolated from the synovium and monocytes from the peripheral blood of rheumatoid arthritis patients were cultured on bone slices and coverslips, in the presence and absence of UMR 106 rat osteoblast-like cells, 1,25-dihydroxy vitamin D3 (1,25(OH)2D3) and macrophage colony stimulating factor (M-CSF), and assessed for cytochemical and functional evidence of osteoclast differentiation.
RESULTS: Isolated calcitonin receptor (CTR), tartrate resistant acid phosphatase (TRAP), and vitronectin receptor (VNR) negative, CD11b and CD14 positive monocytes and macrophages differentiated into CTR, TRAP, and VNR positive multinucleated cells capable of extensive lacunar bone resorption when co-cultured for 14 d with UMR 106 cells in the presence 1,25(OH)2D3 and M-CSF.
CONCLUSIONS: Mononuclear phagocytes (monocytes and macrophages) from rheumatoid arthritis patients are capable of differentiating into multinucleated cells showing all the cytochemical and functional criteria of mature osteoclasts. Synovial macrophage-osteoclast differentiation may represent an important cellular mechanism in the bone destruction associated with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976638      PMCID: PMC1010317          DOI: 10.1136/ard.55.11.816

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  49 in total

1.  Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Authors:  S Kotake; K Sato; K J Kim; N Takahashi; N Udagawa; I Nakamura; A Yamaguchi; T Kishimoto; T Suda; S Kashiwazaki
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

2.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts.

Authors:  R Baron; L Neff; P Tran Van; J R Nefussi; A Vignery
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

Review 4.  Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact.

Authors:  B Henderson; P A Revell; J C Edwards
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

5.  The immunohistology of synovial lining cells in normal and inflamed synovium.

Authors:  N A Athanasou; J Quinn; A Heryet; B Puddle; C G Woods; J O McGee
Journal:  J Pathol       Date:  1988-06       Impact factor: 7.996

6.  Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

Authors:  N Takahashi; H Yamana; S Yoshiki; G D Roodman; G R Mundy; S J Jones; A Boyde; T Suda
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

7.  Failure of cells of the mononuclear phagocyte series to resorb bone.

Authors:  T J Chambers; M A Horton
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

8.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

9.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

Authors:  M A Horton; D Lewis; K McNulty; J A Pringle; T J Chambers
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

10.  Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies.

Authors:  N Hogg; D G Palmer; P A Revell
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

View more
  39 in total

1.  Do sex hormones modulate the synovial macrophages in rheumatoid arthritis?

Authors:  M Cutolo
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

2.  Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype.

Authors:  S D Neale; R Kristelly; R Gundle; J M Quinn; N A Athanasou
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

3.  Stimulation of osteoclast formation by inflammatory synovial fluid.

Authors:  Iannis E Adamopoulos; Lynett Danks; Ichiro Itonaga; Rachel M Locklin; Afsie Sabokbar; David J P Ferguson; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

4.  Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells.

Authors:  A Sabokbar; Y Fujikawa; S Neale; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

5.  Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis.

Authors:  T N Crotti; M D Smith; H Weedon; M J Ahern; D M Findlay; M Kraan; P P Tak; D R Haynes
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

6.  The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis.

Authors:  Laura Masi; Susanna Maddali Bongi; Chiara Angotti; Francesca Del Monte; Silvia Carbonell Sala; Massimo Basetti; Antonietta Amedei; Alberto Falchetti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

7.  Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  E M Gravallese; Y Harada; J T Wang; A H Gorn; T S Thornhill; S R Goldring
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.

Authors:  J Richter; K Capková; V Hříbalová; L Vannucci; I Danyi; M Malý; A Fišerová
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

9.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

10.  Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

Authors:  L Danks; A Sabokbar; R Gundle; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.